• $799.00

Descripción editorial

This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalized cancer medicine. The book takes the reader through definitions of the pharmacodiagnostic concept, historical perspectives of the early steps into molecular cancer diagnostics linked to therapy, the basis of different diagnostic molecular techniques, ongoing research, drug-diagnostic co-development, assay validation, clinical trial methodology, regulatory issues around pharmacodiagnostics and future aspects within personalized cancer medicine.

GÉNERO
Técnicos y profesionales
PUBLICADO
2019
8 de mayo
IDIOMA
EN
Inglés
EXTENSIÓN
352
Páginas
EDITORIAL
Jenny Stanford Publishing
VENTAS
Taylor & Francis Group
TAMAÑO
5
MB